SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: biopicker who wrote (3277)12/10/1997 10:53:00 PM
From: per strandberg   of 6136
 
biopicker,

Thanks a lot for the info on AD3340 and AG2034. Apart for the snippets of information I can pick up on this thread, there is preciously little that I can find on the web about the drugs in the pipeline.

One question, what about arthritis and AG3340? That ought to be as big a market as cancer?

Your evaluation of Viracept was correct but low IMO. On the other hand, the value to AGPH is only half as they have to split the profit with JT. Still, based on fundamentals, AGPH is the best company I can find.

Regards
ps
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News